Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML
Phase 1
Completed
- Conditions
- Myelodysplastic Syndrome
- Interventions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 87
- Registration Number
- NCT00195104
- Locations
- 🇺🇸
Weill Medcial College of Cornell University, New York, New York, United States
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Phase 2
Completed
- Conditions
- Alloimmune ThrombocytopeniaFetal Alloimmune Thrombocytopenia
- Interventions
- Drug: IVIG (Intravenous Immunoglobulin)
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 102
- Registration Number
- NCT00194987
- Locations
- 🇺🇸
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, United States
A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone
Phase 2
Withdrawn
- Conditions
- Idiopathic Thrombocytopenic Purpura (ITP)
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00161564
- Locations
- 🇺🇸
Weill Medical College of Cornell University Division of Pediatric Hematology-Oncology, New York, New York, United States
Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon Gases
Phase 2
- Conditions
- Subretinal Hemorrhage and Exudative Maculopathy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2011-01-04
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 25
- Registration Number
- NCT00161525
- Locations
- 🇺🇸
New York Presbyterian Hospital, New York, New York, United States
Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma
Phase 1
Completed
- Conditions
- T-Cell LymphomaLymphoma, Non-Hodgkin's
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-10-22
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00161590
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery
Phase 4
Completed
- Conditions
- Pain Management Following Cardiopulmonary Bypass Surgery
- Interventions
- Other: Placebo
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-05-13
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 25
- Registration Number
- NCT00161577
- Locations
- 🇺🇸
New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, United States
Use of Sucrose to Relieve Pain During Eye Exams in Infants
Not Applicable
Terminated
- Conditions
- Apnea of PrematurityRetinopathy of PrematurityPain
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-06-04
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 300
- Registration Number
- NCT00161694
- Locations
- 🇺🇸
NYPH - Weill Cornell Medical Center, New York, New York, United States
Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study
Completed
- Conditions
- Angioplasty Patients
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 18
- Registration Number
- NCT00161603
- Locations
- 🇺🇸
The New York Presbyterian Hospital-Weill Medical Center, New York, New York, United States
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 50
- Registration Number
- NCT00151203
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis
Phase 1
Completed
- Conditions
- Late Infantile Neuronal Ceroid LipofuscinosisBatten Disease
- Interventions
- Biological: AAV2CUhCLN2 (3x10^12 particle units)
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2020-07-24
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 10
- Registration Number
- NCT00151216
- Locations
- 🇺🇸
New York Presbyterian Hospital - Weill Medical College of Cornell University, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath